- Home
- TARS vs BTDR Comparison
TARS vs BTDR Comparison
Compare TARS & BTDR Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | TARS | BTDR |
|---|---|---|
| Founded | 2016 | 2021 |
| Country | United States | Singapore |
| Employees | N/A | N/A |
| Industry | Medicinal Chemicals and Botanical Products | EDP Services |
| Sector | Health Care | Technology |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.7B | 3.1B |
| IPO Year | 2020 | 2021 |
Fundamental Metrics
Financial Performance| Metric | TARS | BTDR |
|---|---|---|
| Price | $65.71 | $12.95 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 6 | 10 |
| Target Price | ★ $89.00 | $22.70 |
| AVG Volume (30 Days) | 408.4K | ★ 6.5M |
| Earning Date | 05-05-2026 | 05-14-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 48.21 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $451,360,000.00 | N/A |
| Revenue This Year | $56.56 | $72.51 |
| Revenue Next Year | $29.94 | $40.84 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 146.71 | N/A |
| 52 Week Low | $38.51 | $7.04 |
| 52 Week High | $85.25 | $27.80 |
Technical Indicators
Market Signals| Indicator | TARS | BTDR |
|---|---|---|
| Relative Strength Index (RSI) | 39.66 | 74.39 |
| Support Level | $65.62 | $11.96 |
| Resistance Level | $67.70 | $13.69 |
| Average True Range (ATR) | 3.04 | 0.76 |
| MACD | -0.37 | 0.40 |
| Stochastic Oscillator | 12.62 | 94.00 |
Price Performance
Historical ComparisonAbout TARS Tarsus Pharmaceuticals Inc.
Tarsus Pharmaceuticals Inc is a commercial-stage biopharmaceutical company focused on the development and commercialization of therapeutics, starting with eye care. The company is focused on the development and commercialization of first-in-class therapeutic candidates to provide treatment for ophthalmic conditions. The company's candidate XDEMVY is a novel investigational eye drop to treat blepharitis caused by the infestation of Demodex mites, referred to as Demodex blepharitis. TP-04 for the potential treatment of ocular rosacea and TP-05 for potential Lyme disease prophylaxis and community malaria reduction.
About BTDR Bitdeer Technologies Group
Bitdeer Technologies Group is principally engaged in provision of digital asset mining services. The Company does not conduct any substantive operations on its own but conducts its primary operations through its subsidiaries. Its majority business segments are: proprietary mining, cloud hash rate sharing and cloud hosting. The company operates five proprietary mining datacenters in the United States and Norway, Bhutan and Singapore.